Vivakor, Inc. Files 8-K on Material Agreements & Equity Sales

Ticker: VIVK · Form: 8-K · Filed: Nov 28, 2025 · CIK: 1450704

Vivakor, INC. 8-K Filing Summary
FieldDetail
CompanyVivakor, INC. (VIVK)
Form Type8-K
Filed DateNov 28, 2025
Risk Levelmedium
Pages3
Reading Time4 min
Key Dollar Amounts$569,589.04
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, equity-sale, security-holder-rights

TL;DR

Vivakor filed an 8-K detailing material agreements and equity sales - check for shareholder impact.

AI Summary

Vivakor, Inc. filed an 8-K on November 28, 2025, reporting on events that occurred on November 25, 2025. The filing indicates a material definitive agreement, unregistered sales of equity securities, and material modifications to security holder rights. Specific details regarding the nature of these agreements, the terms of the equity sales, and the modifications to security holder rights are not fully elaborated in the provided text.

Why It Matters

This 8-K filing signals significant corporate actions by Vivakor, Inc., potentially impacting its financial structure and shareholder rights.

Risk Assessment

Risk Level: medium — The filing mentions material definitive agreements, unregistered equity sales, and modifications to security holder rights, which can introduce complexity and potential risks.

Key Players & Entities

FAQ

What was the specific nature of the material definitive agreement entered into by Vivakor, Inc. on November 25, 2025?

The provided text does not specify the details of the material definitive agreement.

What type of equity securities were sold by Vivakor, Inc. in the unregistered sale on November 25, 2025?

The filing indicates unregistered sales of equity securities, but the specific type is not detailed in the provided text.

What were the material modifications made to the rights of Vivakor, Inc.'s security holders?

The filing mentions material modifications to the rights of security holders, but the specific changes are not elaborated in the provided text.

What is the principal executive office address for Vivakor, Inc. as listed in the filing?

The principal executive office address is 5220 Spring Valley Rd., Ste. 500, Dallas, TX 75254.

What is the Commission File Number for Vivakor, Inc.?

The Commission File Number for Vivakor, Inc. is 001-41286.

Filing Stats: 1,029 words · 4 min read · ~3 pages · Grade level 12.8 · Accepted 2025-11-28 17:19:09

Key Financial Figures

Filing Documents

01

Item 1.01 Entry into a Material Agreement. On November 25, 2025, the Company entered into a Debt Satisfaction and Preferred Stock Amendment Agreement (the "Series A Preferred Agreement"), under which the holders of the Company's Series A Preferred Stock agreed to forgo their rights to the Series A Preferred Stock 6% annual dividend from April 30, 2026 to April 29, 2027 in exchange for the Company agreeing to amend the Series A Preferred Stock Certificate of Designation to add voting rights to the rights and preferences of the Series A Preferred Stock. In addition, James Ballengee, the Company's Chief Executive Officer and a member of the Board of Directors, agreed to extinguish the $569,589.04 he is owed under a convertible promissory note as part of the Series A Preferred Agreement. As a result of the Series A Preferred Agreement, the holders of the Series A Preferred own approximately 96,731,000 votes on any matters properly presented to the Company's shareholders, which equated to approximately 35% of the Company's outstanding votes as of the date of the Series A Preferred Agreement. At the Company's 2025 Annual Meeting of Stockholders held September 11, 2025, a majority of the Company's stockholders approved a conversion of the Preferred Stock into Common Stock that exceeds 19.99% of the Company's outstanding common stock if the Company's Board of Directors and executive management elected to convert the Preferred Stock.

01 of this Current Report on Form 8-K contains

Item 1.01 of this Current Report on Form 8-K contains only a brief description of the material terms of the Series A Preferred Agreement and does not purport to be a complete description of the rights and obligations of the parties to the Series A Preferred Agreement, and such description is qualified in its entirety by reference to the full text of the Series A Preferred Agreement, a copy of which is filed herewith as Exhibit 10.1.

02

Item 3.02 Unregistered Sales of Equity Securities. On November 26, 2025, we issued an aggregate of 3,616,310 shares of our restricted common stock for dividends owed on our Series A Preferred Stock for July 31, 2025 and October 31, 2025 to the holders of our Series A Preferred Stock. Of those shares, an aggregate of 1,889,590 shares were issued to Jorgan Development, LLC and JBAH Holdings, LLC, entities controlled by James Ballengee, our Chief Executive Officer, or their assignees. The issuance of the foregoing securities was exempt from registration pursuant to Section 4(a)(2) of the Securities Act promulgated thereunder as the holders sophisticated investors and familiar with our operations. On November 26, 2025, we issued 1,557,808 shares of our restricted common stock to a consultant under the terms of a Consulting Agreement. The issuance of the foregoing securities was exempt from registration pursuant to Section 4(a)(2) of the Securities Act promulgated thereunder as the holders sophisticated investors and familiar with our operations. On November 26, 2025, we issued 82,500 shares of our restricted common stock to an investor as inducement shares under a previously disclosed Securities Purchase Agreement. The issuance of the foregoing securities was exempt from registration pursuant to Section 4(a)(2) of the Securities Act promulgated thereunder as the holders sophisticated investors and familiar with our operations.

03

Item 3.03 Material Modification to Rights of Security Holders. As disclosed in Item 1.01 above, the Company filed an Amended and Restated Certificate of Designation for its Series A Preferred Stock to add voting rights to the rights and preferences of the Series A Preferred Stock. As a result of the amendment, the holders of the Series A Preferred own 96,731,000 votes on any matters properly presented to the Company's shareholders, which equated to approximately 35% of the Company's outstanding votes as of the date of the Series A Preferred Agreement. A copy of the Company's Amended and Restated Certificate of Designation for its Series A Convertible Preferred Stock is attached hereto as Exhibit 3.1. 1

Financial Statements and Exhibits

Financial Statements and Exhibits. Exhibit No. Exhibit 3.1 Amended and Restated Series A Convertible Preferred Stock Certificate of Designation 10.1 Debt Satisfaction and Preferred Stock Amendment Agreement 104 Cover Page Interactive Data File (formatted as Inline XBRL document). 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VIVAKOR, INC. Dated: November 28, 2025 By: /s/ James Ballengee Name: James Ballengee Title: Chairman, President, and CEO 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing